Adelle Bricking
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Adelle Bricking has a total of 97 co-authors. Here are the top co-authors by number of shared publications:
- Alexandre Gilardet
Centre for Palaeogenetics, Stockholm, Sweden
2 shared publications - Christopher Barrington
Bioinformatics and Biostatistics, The Francis Crick Institute, London, UK
2 shared publications - Frankie Tait
Ancient genomics laboratory, The Francis Crick Institute, London, United Kingdom
2 shared publications - Ian Armit
University of York
2 shared publications Isabelle Glocke
Ancient genomics laboratory, The Francis Crick Institute, London, United Kingdom
2 shared publications- Jesse McCabe
Ancient genomics laboratory, The Francis Crick Institute, London, United Kingdom
2 shared publications
Latest Publications
- Open Access
Genomic history and selection in Roman and early medieval Britain
Leading biomedical resources rely on genome variation in Britain 1–3 , but the historical processes that shaped present-day fine-scale diversity remain debated 4–13 . Here we sequenced 1039 ancient shotgun genomes from Britain (median 1.4-fold coverage), primarily dating to the first millennium CE. We imputed ∼660 million variants in the UK Biobank 14–16 and employed genealogy-based ancestry reconstruction. We found an association between Iron Age consanguinity and matrilineal burial practices 17 , later disrupted following the Roman Conquest. Despite this societal impact, only 20% of Roman-period individuals carried detectable ancestry from outside Britain. In contrast, from the 6th century CE we detect widespread influx of ancestry in over 70% of individuals in southern’Anglo-Saxon’ Britain, with limited local admixture. We find previously underappreciated heterogeneity, with ancestries associated with Central and Southern Europe rising in prevalence from the 7th century CE. We demonstrate distinct Scandinavian-related ancestry in many Viking-associated contexts, but show that the population-level impact of the Viking Age in Britain was limited. Finally, we detect pre-medieval selection on variants linked with key immunity genes TLR10-TLR1 and IRF8 . These results identify population-level and selective processes that shape variation and disease risk in Britain today.
Open AccessGenomic history and selection in Roman and early medieval Britain
Leading biomedical resources rely on genome variation in Britain 1–3 , but the historical processes that shaped present-day fine-scale diversity remain debated 4–13 . Here we sequenced 1039 ancient shotgun genomes from Britain (median 1.4-fold coverage), primarily dating to the first millennium CE. We imputed ∼660 million variants in the UK Biobank 14–16 and employed genealogy-based ancestry reconstruction. We found an association between Iron Age consanguinity and matrilineal burial practices 17 , later disrupted following the Roman Conquest. Despite this societal impact, only 20% of Roman-period individuals carried detectable ancestry from outside Britain. In contrast, from the 6th century CE we detect widespread influx of ancestry in over 70% of individuals in southern’Anglo-Saxon’ Britain, with limited local admixture. We find previously underappreciated heterogeneity, with ancestries associated with Central and Southern Europe rising in prevalence from the 7th century CE. We demonstrate distinct Scandinavian-related ancestry in many Viking-associated contexts, but show that the population-level impact of the Viking Age in Britain was limited. Finally, we detect pre-medieval selection on variants linked with key immunity genes TLR10-TLR1 and IRF8 . These results identify population-level and selective processes that shape variation and disease risk in Britain today.
- Open Access
- 22 May 2025
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 388 (6749) , eadr2147
Ancient Borrelia genomes document the evolutionary history of louse-borne relapsing fever
Several bacterial pathogens have transitioned from tick-borne to louse-borne transmission, which often involves genome reduction and increasing virulence. However, the timing of such transitions remains unclear. We sequenced four ancient Borrelia recurrentis genomes, the agent of louse-borne relapsing fever, dating from 2300 to 600 years ago. We estimated the divergence from its closest tick-borne relative to 6000 to 4000 years ago, which suggests an emergence coinciding with human lifestyle changes such as the advent of wool-based textiles. Pan-genome analysis indicated that much of the evolution characteristic of B. recurrentis had occurred by ~2300 years ago, though further gene turnover, particularly in plasmid partitioning, persisted until ~1000 years ago. Our findings provide a direct genomic chronology of the evolution of this specialized vector-borne pathogen.
- 22 May 2025
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 388 (6749) , eadr2147
Open AccessAncient Borrelia genomes document the evolutionary history of louse-borne relapsing fever
Several bacterial pathogens have transitioned from tick-borne to louse-borne transmission, which often involves genome reduction and increasing virulence. However, the timing of such transitions remains unclear. We sequenced four ancient Borrelia recurrentis genomes, the agent of louse-borne relapsing fever, dating from 2300 to 600 years ago. We estimated the divergence from its closest tick-borne relative to 6000 to 4000 years ago, which suggests an emergence coinciding with human lifestyle changes such as the advent of wool-based textiles. Pan-genome analysis indicated that much of the evolution characteristic of B. recurrentis had occurred by ~2300 years ago, though further gene turnover, particularly in plasmid partitioning, persisted until ~1000 years ago. Our findings provide a direct genomic chronology of the evolution of this specialized vector-borne pathogen.